SERENITY: Mindfulness-Based Cancer Recovery program for patients living with a gynecological cancer: a pilot randomized controlled study
Indication :

gynecological cancer


Sponsor :

HUG


Phase :

autre


Ligne :

Any


Traitement :

Meditation


Site :

CHUV, HUG


Contact(s) :
Dr Alexandre Bodmer
Principal Investigator

HUG
Oncology

Rue Gabrielle Perret-Gentil, 4
1211
Geneva

+41795532405
Alexandre.Bodmer@hcuge.ch
Benedicte Fleury
Study Coordinator

HUG
Oncology

Rue Gabrielle Perret-Gentil, 4
GENEVA
1211

+41795534031
benedicte.fleury@hcuge.ch
Pr. Manuela EICHER
Principal Investigator

CHUV
Institute of Higher Education and Research in Healthcare

Rue du Bugnon, 46
LAUSANNE
1011

+41 21 314 87 60
manuela.eicher@chuv.ch

Primary objective :

Since this is a pilot study, the primary aim is to explore the feasibility of the intervention and the study design.


Inclusion criteria :

• Signed study consent
• ≥ 18 years
• Being a woman
• Being diagnosed with breast or any gynecological cancer (either ovarian, cervical, vulvar, womb or vaginal cancer), stages I to IV.
• For women with localized cancers: having completed all adjuvant treatments, such as surgery, chemotherapy and/or radiotherapy, at least 3 months previously, with the exception of hormonal, immune and targeted therapy,
• For women with metastatic cancers: having a performance status < 3, not undergoing IV chemotherapy and having a life expectancy more than 9 months as estimated by their treating oncologist.
• Free from acute infection for 2 weeks before biochemical assessment.
• Speaking and reading French fluently


Exclusion criteria :

• Inability to follow the procedures of the study due to:

  • Significant deafness
  • Physical impairment that prevents attending the sessions
  • Mental retardation (ICD-10)
  • Dementia (ICD-10)
  • Depression (ICD-10) *
  • Spectrum disorder of schizophrenia (ICD-10) **
  • Alcohol or other substance dependence (ICD-10) **
  • Emotionally labile personality disorder that is incompatible with group participation (ICD-10) **
  • A post-traumatic stress disorder (PTSD) (ICD-10)**

• Currently engages in meditation one or more times per week
• Previous participation in MBCR program
• Serious physiological illnesses that would interfere with the interpretation of biochemical data (e.g., anemia, diabetes, cardiovascular diseases, blood cancers, inflammatory bowel diseases, autoimmune diseases, asthma being treated with steroids, immunodeficiency)